![Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19 | McGill University Health Centre Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19 | McGill University Health Centre](https://muhc.ca/sites/default/files/news/Press-releases/Jean_Bourbeau_image.jpg)
Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19 | McGill University Health Centre
![Widespread off-label use of epilepsy medications could put some patients at risk | McGill University Health Centre Widespread off-label use of epilepsy medications could put some patients at risk | McGill University Health Centre](https://muhc.ca/sites/default/files/2019-07/elderly-woman-prescription-image_0.jpg)
Widespread off-label use of epilepsy medications could put some patients at risk | McGill University Health Centre
![Veteran CTV News Montreal Journalist Annie DeMelt joins McGill University Health Centre Communications Team | McGill University Health Centre Veteran CTV News Montreal Journalist Annie DeMelt joins McGill University Health Centre Communications Team | McGill University Health Centre](https://muhc.ca/sites/default/files/news/Press-releases/annie-demelt.jpg)